|
| 36271929 | Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. | Acta Neuropathol | 2023 |
| 35639513 | Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial. | Neuro Oncol | 2023 |
| 36271929 | Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. | Acta Neuropathol | 2023 |
| 37722087 | Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. | J Clin Oncol | 2023 |
| 37720388 | An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah. | Neurooncol Pract | 2023 |
| 36974606 | Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study. | Future Oncol | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 36747658 | Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis. | bioRxiv | 2023 |
| 37488293 | Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. | Nat Med | 2023 |
| 37720388 | An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah. | Neurooncol Pract | 2023 |
| 37488293 | Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. | Nat Med | 2023 |
| 37722087 | Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. | J Clin Oncol | 2023 |
| 35639513 | Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial. | Neuro Oncol | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 36974606 | Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study. | Future Oncol | 2023 |
| 36747658 | Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis. | bioRxiv | 2023 |
| 34561270 | Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma. | Clin Cancer Res | 2022 |
| 36358918 | Replicative Instability Drives Cancer Progression. | Biomolecules | 2022 |
| 35764907 | Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis. | J Neurooncol | 2022 |
| 35380705 | Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors. | Neuro Oncol | 2022 |
| 35554777 | Factors associated with changes in exercise behaviors during the COVID-19 pandemic. | Cancer Causes Control | 2022 |
| 36201019 | Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions. | Acta Neuropathol | 2022 |
| 36455274 | Editorial. The Raman effect on intraoperative diagnosis of central nervous system tumors. | Neurosurg Focus | 2022 |
| 34792647 | Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma. | Support Care Cancer | 2022 |
| 34510238 | Caregiver burden by treatment and clinical characteristics of patients with glioblastoma. | Support Care Cancer | 2022 |
| 34561270 | Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma. | Clin Cancer Res | 2022 |
| 35175291 | Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. | Arch Pathol Lab Med | 2022 |
| 35243690 | Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. | J Rural Health | 2022 |
| 35380705 | Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors. | Neuro Oncol | 2022 |
| 35764907 | Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis. | J Neurooncol | 2022 |
| 35554777 | Factors associated with changes in exercise behaviors during the COVID-19 pandemic. | Cancer Causes Control | 2022 |
| 36455274 | Editorial. The Raman effect on intraoperative diagnosis of central nervous system tumors. | Neurosurg Focus | 2022 |
| 36358918 | Replicative Instability Drives Cancer Progression. | Biomolecules | 2022 |
| 36201019 | Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions. | Acta Neuropathol | 2022 |
| 35243690 | Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. | J Rural Health | 2022 |
| 35175291 | Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. | Arch Pathol Lab Med | 2022 |
| 34792647 | Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma. | Support Care Cancer | 2022 |
| 34510238 | Caregiver burden by treatment and clinical characteristics of patients with glioblastoma. | Support Care Cancer | 2022 |
| 32749900 | Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer. | J Adolesc Young Adult Oncol | 2021 |
| 33692132 | A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. | Sci Transl Med | 2021 |
| 34215688 | Systematic review of combinations of targeted or immunotherapy in advanced solid tumors. | J Immunother Cancer | 2021 |
| 34137219 | First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma. | Cancer Rep (Hoboken) | 2021 |
| 33199490 | Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma. | Clin Cancer Res | 2021 |
| 32749900 | Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer. | J Adolesc Young Adult Oncol | 2021 |
| 33130879 | Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials. | Neuro Oncol | 2021 |
| 34580667 | Impact of the COVID-19 pandemic on exercise habits among cancer patients. | Res Sq | 2021 |
| 35088051 | Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial. | Neurooncol Adv | 2021 |
| 33692132 | A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. | Sci Transl Med | 2021 |
| 35088051 | Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial. | Neurooncol Adv | 2021 |
| 34580667 | Impact of the COVID-19 pandemic on exercise habits among cancer patients. | Res Sq | 2021 |